Vilazodone Hydrochloride Tablet
Product Images NDC 68788-8735

This text appears to be a description of Vilazodone HCI Tablets 40mg, a prescription medication used as a generic for Viibryd. It provides information on the drug's composition, manufacturer (MSN Laboratories Pvt. Ltd.), and warnings about its use. The text also includes details such as lot number, expiration date, batch number, and packaging size. Additionally, it highlights caution against transferring the medication to any person other than the prescribed patient and advises keeping all drugs out of the reach of children.*

This text provides information about changes in pharmacokinetics (PK) due to fold change and 90% confidence intervals (CI) for various substances, including Ethanol, CYP3A4 Inhibitors, CYP3A4 Inducers, and Proton Pump Inhibitors. It details the Crmax and AUC values for different substances and their impact on pharmacokinetics. The text also mentions changes relative to a reference point.*

Description: This text presents information on the change in PK Fold Change and 90% Confidence Interval for various drug substrates metabolized by different cytochrome P450 enzymes and P-glycoprotein. It includes details such as area under plasma concentration-time curve, plasma concentration ratio, urinary recovery ratio, renal clearance, and maximal plasma concentration for different substrates like nifedipine, caffeine, debrisoquine, flurbiprofen, mephenytoin, and digoxin. This information is essential for understanding the impact of enzyme polymorphisms on drug metabolism and bioavailability.*

Population Description: This text provides information on the population characteristics for a study or research project. The population includes individuals who are older than 65 years old and females. It also categorizes renal impairment as mild, moderate, or severe, and hepatic impairment as mild, moderate, or severe. The data presented includes PK parameters such as AUC and AuC, along with fold change and 90% CI for comparison. The population comparisons are based on age, gender, renal impairment status, and hepatic impairment compared to normal function. The data concerning elderly subjects are in relation to younger subjects (24-55 years), and for female subjects in relation to male subjects. This information could be used to analyze the impact of age, gender, and organ impairment on the pharmacokinetics of a substance.*

This text provides information about Vilazodone HCI Tablets in 20mg strength, indicating it is a generic version of Viibryd. It includes details on the manufacturer (MSN Laboratories Pvt. Ltd.), quantity, lot numbers, warnings, and instructions. The description also mentions that federal law prohibits the transfer of this medication to anyone other than the patient for whom it was prescribed, emphasizing caution. Additionally, it includes details like the appearance of the tablets (oval, orange, and imprinted with MV / 15) and instructions for storage. The text emphasizes the importance of keeping the medication out of reach of children.*